Related Experiment Videos
Persistent redundant Eustachian valve interfering with Amplatzer PFO occluder placement: anatomico-clinical and
Eustaquio Onorato1, Isidoro G Pera, Gloria Melzi
1Division of Cardiology, Clinica San Rocco di Franciacorta, Ome, Brescia, Italy. eonorato@libero.it
Summary
Transcatheter closure of patent foramen ovale (PFO) using an Amplatzer device can lead to unintentional extraction of prominent Eustachian valve tissue. This case highlights potential complications during PFO closure procedures.
Area of Science:
- Cardiology
- Interventional Cardiology
- Medical Devices
Background:
- Patent foramen ovale (PFO) is a common cardiac anomaly.
- Transient ischemic attack (TIA) is a potential complication of PFO.
- Transcatheter closure is a standard PFO treatment.
Observation:
- A 28-year-old male with PFO and a prominent Eustachian valve presented with TIA.
- Transcatheter PFO closure was performed using an Amplatzer occluder.
- During device deployment, Eustachian valve tissue became entrapped and was unintentionally extracted.
Findings:
- The Amplatzer PFO occluder deployment was complicated by entrapment of prominent Eustachian valve tissue.
- A portion of the Eustachian valve was unintentionally removed during the procedure.
- The anatomical and technical aspects of this complication were analyzed.
Implications:
- This event underscores the importance of careful device manipulation during PFO closure.
- Prominent Eustachian valve tissue may pose a risk of entrapment and avulsion.
- Understanding these risks is crucial for optimizing transcatheter PFO closure techniques.